Pinned straw:
Nanosonic added more details about Trophon's business performance by excluding operating expenses related to the development and commercialization preparation of CORIS.
Why is this given now?
Solvetheriddle
@Valueinvestor0909 good pick up, sculpting the c suite bonus imo not a good look
mikebrisy
Has someone calculated they are going to lose a lot of personal value if the new product timeline gets extended and it is going to cost a lot more? Does the Board have the power to do this without shareholder agreement? (Presumably so.)
On the face of it, this is poor governance. I would understand having a COO's incentives de-tuned from R&D performance, but not the CEO and CFO.
Innovation performance should be tied to long term inventives. I think this is very odd.
Disc: Not held but on watch list.